Markets:

Overview

News

Currencies

International

Treasuries

Omnicell, Inc. - Common Stock (NQ:OMCL)

42.65 -0.51 (-1.19%)

Streaming Delayed Price Updated: 11:25 AM EDT, Jun 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Omnicell, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Omnicell Announces Third Quarter 2023 Results; Updates Fiscal Year 2023 Guidance and Announces Reduction in Force

November 02, 2023

From Omnicell, Inc.

Via Business Wire

Omnicell to Release Third Quarter 2023 Financial Results on November 2, 2023

October 16, 2023

From Omnicell, Inc.

Via Business Wire

Analyst Expectations for Omnicell's Future ↗

October 03, 2023

Via Benzinga

Airbnb, Blackstone Rise On News They'll Join S&P 500 Index ↗

September 02, 2023

ABNB and BX will join Sept. 18 as part of a quarterly rebalancing.

Via Investor's Business Daily

Topics Stocks

4 Analysts Have This to Say About Omnicell ↗

July 20, 2023

Via Benzinga

Analyst Expectations for Omnicell's Future ↗

March 01, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2023 ↗

October 11, 2023

Via Benzinga

Omnicell Inc. Unusual Options Activity: Slightly OTM Call Buying With Relative Size ↗

August 30, 2023

Omnicell Inc. (NASDAQ: OMCL) experienced notable options activity. The majority of the trading volume centered around a single trade involving 300 contracts at a strike price of $60, with a premium of...

Via Benzinga

Omnicell to Present at the 2023 Wells Fargo Healthcare Conference

August 23, 2023

From Omnicell, Inc.

Via Business Wire

Earnings Preview For Omnicell ↗

February 27, 2023

Via Benzinga

6 Analysts Have This to Say About Omnicell ↗

January 24, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2023 ↗

August 02, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 01, 2023

Via Benzinga

Omnicell Announces Second Quarter 2023 Results

August 01, 2023

From Omnicell, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2023 ↗

July 20, 2023

Via Benzinga

Top Investment Bank Unveils 3 ETFs, 10 Stocks To Buy In The AI Boom ↗

July 12, 2023

Via Benzinga

Omnicell to Release Second Quarter 2023 Financial Results on August 1, 2023

July 12, 2023

From Omnicell, Inc.

Via Business Wire

Omnicell Appoints Bobby Ghoshal to Board of Directors

July 11, 2023

From Omnicell, Inc.

Via Business Wire

Omnicell Announces Leadership and Organizational Changes

May 30, 2023

From Omnicell, Inc.

Via Business Wire

Omnicell Appoints Nchacha E. Etta as Executive Vice President and Chief Financial Officer

May 15, 2023

From Omnicell, Inc.

Via Business Wire

Omnicell to Present at the BofA Securities 2023 Healthcare Conference

May 03, 2023

From Omnicell, Inc.

Via Business Wire

Omnicell Announces First Quarter 2023 Results

May 02, 2023

From Omnicell, Inc.

Via Business Wire

Long Island University and Omnicell Launch Center for Innovative Medication Management

April 20, 2023

From Omnicell, Inc.

Via Business Wire

Omnicell to Release First Quarter 2023 Financial Results on May 2, 2023

April 12, 2023

From Omnicell, Inc.

Via Business Wire

Omnicell Announces Fiscal Year and Fourth Quarter 2022 Results

February 28, 2023

From Omnicell, Inc.

Via Business Wire

Earnings Scheduled For February 28, 2023 ↗

February 28, 2023

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 27, 2023 ↗

February 27, 2023

Via Benzinga

CORRECTING and REPLACING Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023

February 16, 2023

From Omnicell, Inc.

Via Business Wire

Amazon To Rally Over 28%? Here Are 10 Other Analyst Forecasts For Tuesday ↗

January 24, 2023

Citigroup raised the price target for AT&T Inc. (NYSE: T) from $20 to $22. Citigroup analyst Michael Rollins maintained a Buy rating. AT&T shares fell 1% to $18.91 in pre-market trading.

Via Benzinga

Omnicell to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 05, 2023

From Omnicell, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.